Jorden David Emerson's Form 4 filing
Nuo Therapeutics, Inc. (AURX) · filed Nov 14, 2022
- Accession no.
- 0001437749-22-027386
- Filed
- Nov 14, 2022
- Trade date
- Nov 9, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $243.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jorden David EmersonCIK 0001313516 | Director, Officer (CEO/CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2022 | Common Stock | SSaleDisposed | −30,000 | $1.50 | −$45,000 | 2,107,858 | Direct | |
| Nov 9, 2022 | Common Stock | SSaleDisposed | −30,000 | $1.50 | −$45,000 | 2,077,858 | Direct | |
| Nov 9, 2022 | Common Stock | SSaleDisposed | −27,000 | $1.50 | −$40,500 | 2,050,858 | Direct | |
| Nov 9, 2022 | Common Stock | SSaleDisposed | −20,000 | $1.50 | −$30,000 | 2,030,858 | Direct | |
| Nov 9, 2022 | Common Stock | SSaleDisposed | −20,000 | $1.50 | −$30,000 | 2,010,858 | Direct | |
| Nov 9, 2022 | Common Stock | SSaleDisposed | −13,500 | $1.50 | −$20,250 | 1,997,358 | Direct | |
| Nov 9, 2022 | Common Stock | SSaleDisposed | −10,000 | $1.50 | −$15,000 | 1,987,358 | Direct | |
| Nov 9, 2022 | Common Stock | SSaleDisposed | −7,000 | $1.50 | −$10,500 | 1,980,358 | Direct | |
| Nov 9, 2022 | Common Stock | SSaleDisposed | −5,000 | $1.50 | −$7,500 | 1,975,358 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.